Opioid painkillers can provide much-needed relief from many painful conditions. But long term use of these medications can increase the chances of having erectile dysfunction in some men.

When cancer begins to spread from its original site, the bones are a common destination. Now, men with advanced prostate cancer have a new option that may help them live longer.

Major medical organizations no longer recommend regular prostate cancer screening for most men. A new study looked at how lethal prostate cancer is in areas where screenings are low.

In men with type 2 diabetes, testosterone levels are likely to be low. Increasing the male hormone may help patients control the disease by decreasing their insulin resistance.

Some men might find it embarrassing or difficult to seek treatment for sexual problems. Though a lot of men with erectile dysfunction make it to the doctor for help, only a few actually take it to the next step.

PSA tests are no longer recommended for men as screens for prostate cancer. Those are the new guidelines released today by the American Urological Association (AUA).

Prostate cancer is the most common cancer in men. Fortunately, it’s not a fatal cancer for most men. New research has found that one medication that’s used to lower cholesterol may also lower prostate cancer deaths.

Obesity increases a person’s risk of a variety of cancers. This connection now appears to affect men who have been tested for and found not to have prostate cancer.

While the incidence of prostate cancer is greater in older men, the screening guidelines are murky. A new study analyzed what happened after older men were screened. 

The statistics are pretty clear that most American men are not going to die of prostate cancer. But the question remains: who should be screened and how often? A new crystal ball may be on the horizon.